2-(4-chloro-3-methylphenoxy)-N-(4-(4-ethoxy-3-methylphenyl)-1,2,5-oxadiazol-3-yl)acetamide

ID: ALA4789677

Chembl Id: CHEMBL4789677

PubChem CID: 17014063

Max Phase: Preclinical

Molecular Formula: C20H20ClN3O4

Molecular Weight: 401.85

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOc1ccc(-c2nonc2NC(=O)COc2ccc(Cl)c(C)c2)cc1C

Standard InChI:  InChI=1S/C20H20ClN3O4/c1-4-26-17-8-5-14(9-13(17)3)19-20(24-28-23-19)22-18(25)11-27-15-6-7-16(21)12(2)10-15/h5-10H,4,11H2,1-3H3,(H,22,24,25)

Standard InChI Key:  ZZRBFWPPJIFCSV-UHFFFAOYSA-N

Associated Targets(Human)

SENP1 Tchem Sentrin-specific protease 1 (681 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SENP2 Tchem Sentrin-specific protease 2 (79 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 401.85Molecular Weight (Monoisotopic): 401.1142AlogP: 4.42#Rotatable Bonds: 7
Polar Surface Area: 86.48Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 7.75CX Basic pKa: CX LogP: 4.77CX LogD: 4.62
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.63Np Likeness Score: -1.94

References

1. Wang Z,Liu Y,Zhang J,Ullah S,Kang N,Zhao Y,Zhou H.  (2020)  Benzothiophene-2-carboxamide derivatives as SENPs inhibitors with selectivity within SENPs family.,  204  [PMID:32717481] [10.1016/j.ejmech.2020.112553]
2. Hua D, Wu X..  (2022)  Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases.,  233  [PMID:35247754] [10.1016/j.ejmech.2022.114227]
3. Wei J, Wang H, Zheng Q, Zhang J, Chen Z, Wang J, Ouyang L, Wang Y..  (2022)  Recent research and development of inhibitors targeting sentrin-specific protease 1 for the treatment of cancers.,  241  [PMID:35939992] [10.1016/j.ejmech.2022.114650]

Source